U.S. markets closed

Veradigm Inc. (MDRX)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
12.57-0.11 (-0.87%)
At close: 04:00PM EDT
12.57 0.00 (0.00%)
After hours: 04:02PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Price Crosses Moving Average

Price Crosses Moving Average

Previous Close12.68
Bid12.56 x 800
Ask12.57 x 1400
Day's Range12.35 - 12.77
52 Week Range11.30 - 19.77
Avg. Volume849,925
Market Cap1.373B
Beta (5Y Monthly)0.93
PE Ratio (TTM)14.96
EPS (TTM)0.84
Earnings DateSep 21, 2023 - Oct 05, 2023
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateOct 07, 2008
1y Target Est17.50
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
-10% Est. Return

Subscribe to Yahoo Finance Plus to view Fair Value for MDRX

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Veradigm Inc.
    Analyst Report: Veradigm IncVeradigm, formerly Allscripts Healthcare Solutions, is a provider of electronic health record solutions for physicians, group practices, ambulatory facilities, and hospitals. The company also provides practice management systems, clinical software, and connectivity solutions for physicians. The company has approximately 8,000 employees.
    Fair Value
    Economic Moat
    3 months agoArgus Research
View more
  • Business Wire

    Veradigm Inc. Provides Audit Update and Updates Financial Guidance for 2023

    CHICAGO, September 18, 2023--Veradigm Inc. (Nasdaq: MDRX) announced today that the work effort to conclude on its previously disclosed accounting and internal control errors has taken longer than previously expected, and more time is needed to complete its audit procedures. As such, today the Company will not be filing its Annual Report on Form 10-K for the year ended December 31, 2022 (the "Form 10-K"), or its Quarterly Reports on Forms 10-Q for the quarters ended March 31, 2023, and June 30, 2

  • GlobeNewswire

    Melissa Supports Healthcare Practice Management Providers with Project US@ Data Compliance

    Federal guidelines embrace importance of patient addresses for health IT developers powering analytics, patient matching, and overall careRANCHO SANTA MARGARITA, Calif., Aug. 30, 2023 (GLOBE NEWSWIRE) -- Melissa, a leading provider of global data quality, identity verification, and address management solutions, today announced its support of healthcare practice management providers in meeting compliance with Project US@, a federal data initiative to create a unified, industrywide specification f

  • Business Wire

    Veradigm Inc. Receives Nasdaq Notice Regarding Delayed Form 10-Q Filing

    CHICAGO, August 18, 2023--Veradigm Inc. (NASDAQ: MDRX) announced today that, as expected, it received a notice from Nasdaq indicating that the Company remains noncompliant with Nasdaq Listing Rule 5250(c)(1) because the Company has not filed its Annual Report on Form 10-K for the year ended December 31, 2022 (the "Form 10-K"), Quarterly Report on Form 10-Q for the quarter ended March 31, 2023 (the "Q1 Form 10-Q") and Quarterly Report on Form 10-Q for the quarter ended June 30, 2023 (the "Q2 Form